MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-06-2025
iTeos Therapeutics Total Current Liabilities 2011-2026 | ITOS
Annual Total Current Liabilities iTeos Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.4 M | 40 M | 42 M | 304 M | 15 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 304 M | 15 M | 88.3 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K |  USA |
 |
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
395 M | $ 22.56 | 2.11 % | $ 3.74 B | USA |
 |
AlloVir
ALVR
|
9.71 M | - | 4.14 % | $ 49.1 M | USA |
 |
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | USA |
 |
Applied Therapeutics
APLT
|
71.2 M | - | - | $ 8.42 M | USA |
 |
I-Mab
IMAB
|
576 M | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
1.47 B | $ 325.5 | 1.87 % | $ 42.6 B | USA |
 |
AVROBIO
AVRO
|
6.35 M | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M |  Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
BeiGene, Ltd.
BGNE
|
1.83 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
CymaBay Therapeutics
CBAY
|
36.8 M | - | - | $ 3.45 B | USA |
 |
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
158 M | $ 20.46 | -0.58 % | $ 956 M | USA |
 |
Aquestive Therapeutics
AQST
|
47.6 M | $ 4.17 | 0.85 % | $ 446 M | USA |
 |
Avid Bioservices
CDMO
|
70.6 M | - | - | $ 789 M | USA |
 |
Cidara Therapeutics
CDTX
|
49.6 M | - | - | $ 1.41 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
Arcutis Biotherapeutics
ARQT
|
130 M | $ 24.6 | 5.72 % | $ 3.13 B | USA |
 |
Cabaletta Bio
CABA
|
50.2 M | $ 3.08 | 0.33 % | $ 309 M | USA |
 |
Checkpoint Therapeutics
CKPT
|
20.1 M | - | - | $ 169 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
9.38 M | - | - | $ 231 M | USA |
 |
AgeX Therapeutics
AGE
|
3.56 M | - | -10.17 % | $ 12.2 K | USA |
 |
Concert Pharmaceuticals
CNCE
|
16.1 M | - | - | $ 401 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
73.4 M | $ 1.5 | 9.93 % | $ 399 M |  Britain |
 |
CTI BioPharma Corp.
CTIC
|
81.1 M | - | - | $ 1.2 B | USA |
 |
AIkido Pharma
AIKI
|
1.61 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
9.31 M | - | -45.71 % | $ 1.2 M |  Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
1.33 M | - | -4.36 % | $ 27 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
100 M | - | - | $ 2.18 B | USA |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
78.6 M | - | - | $ 2.02 B | USA |
 |
Akari Therapeutics, Plc
AKTX
|
12.4 M | $ 3.86 | 1.58 % | $ 260 B | Britain |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
36.6 M | - | - | $ 28.6 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | USA |
 |
Enochian Biosciences
ENOB
|
29.2 M | - | - | $ 40.5 M | USA |
 |
Curis
CRIS
|
14.1 M | $ 0.55 | 0.49 % | $ 7.24 M | USA |